Cargando…

Sequentially immune‐induced antibodies could cross‐neutralize SARS‐CoV‐2 variants

BACKGROUND: The Omicron (B.1.1.529) SARS‐COV‐2 variant has raised serious concerns because of its unprecedented rapid rate of spreading and the fact that there are 36 mutations in the spike protein. Since the vaccine‐induced neutralizing antibody targets are the spike protein, this may lead to the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Qi, Zhou, Shasha, Qi, Feifei, Zhang, Yaqing, Li, Fengdi, Liu, Mingya, Bao, Linlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879626/ https://www.ncbi.nlm.nih.gov/pubmed/35213787 http://dx.doi.org/10.1002/ame2.12216

Ejemplares similares

Comparison of the replication and neutralization of different SARS‐CoV‐2 Omicron subvariants in vitro
por: Zhang, Yaqing, et al.
Publicado: (2023)

Sequential immunizations confer cross-protection against variants of SARS-CoV-2, including Omicron in Rhesus macaques
por: Deng, Wei, et al.
Publicado: (2022)

Sensitivity of SARS‐CoV‐2 to different temperatures
por: Lv, Qi, et al.
Publicado: (2020)

Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza
por: Bao, Linlin, et al.
Publicado: (2021)

Interleukin-37 Ameliorates Influenza Pneumonia by Attenuating Macrophage Cytokine Production in a MAPK-Dependent Manner
por: Qi, Feifei, et al.
Publicado: (2019)

Structural and functional analysis of a potent human neutralizing antibody against enterovirus A71
por: Chen, Zhe, et al.
Publicado: (2022)

Neutralizing Antibody Response to Sarbecovirus Is Delayed in Sequential Heterologous Immunization
por: Lv, Huibin, et al.
Publicado: (2022)

Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study
por: Hormazábal, Juan, et al.
Publicado: (2023)

Intramuscular injection of a mixture of COVID-19 peptide vaccine and tetanus vaccine in horse induced neutralizing antibodies against authentic virus of SARS-CoV-2 Delta variant
por: Deng, Weiwen, et al.
Publicado: (2022)

Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
por: Deng, Wei, et al.
Publicado: (2020)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice
por: Song, Shuo, et al.
Publicado: (2022)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021)

Could anti-ACE2 antibodies alter the results of SARS-CoV-2 Ab neutralization assays?
por: Tobes, Raquel, et al.
Publicado: (2022)

Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
por: Cho, Hyeseon, et al.
Publicado: (2021)

Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies
por: Qiu, Hongyu, et al.
Publicado: (2021)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization
por: Guo, Huimin, et al.
Publicado: (2022)

Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization
por: Zhang, Li, et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants
por: Li, Yaning, et al.
Publicado: (2022)

SARS-CoV-2 Causes a Systemically Multiple Organs Damages and Dissemination in Hamsters
por: Song, Zhiqi, et al.
Publicado: (2021)

Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
por: Azevedo, Patrick O., et al.
Publicado: (2023)

Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
por: Shan, Sisi, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
por: Wang, Ruoke, et al.
Publicado: (2022)

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
por: Zhou, Guangyu, et al.
Publicado: (2020)

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
por: Weisblum, Yiska, et al.
Publicado: (2020)

Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
por: Wang, Pengfei, et al.
Publicado: (2021)

Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization
por: Wang, Pengfei, et al.
Publicado: (2021)

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
por: Favorskaya, Irina A., et al.
Publicado: (2022)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
por: Sharun, Khan, et al.
Publicado: (2021)

Human-Derived A/Guangdong/Th005/2017 (H7N9) Exhibits Extremely High Replication in the Lungs of Ferrets and Is Highly Pathogenic in Chickens
por: Gong, Shuran, et al.
Publicado: (2019)

Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
por: Bajpai, Prashant, et al.
Publicado: (2022)

Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern
por: Valdovino-Navarro, Blanca J., et al.
Publicado: (2022)

Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants
por: Ko, Hae Li, et al.
Publicado: (2023)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
por: Tran, Trung The, et al.
Publicado: (2022)

Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage
por: Jiang, Wen, et al.
Publicado: (2022)

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
por: Gao, Xingsu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5rqeur81vp33t820j07a3qbs82